These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 30690680)
1. Dissolution Testing in Drug Product Development: Workshop Summary Report. Abend A; Curran D; Kuiper J; Lu X; Li H; Hermans A; Kotwal P; Diaz DA; Cohen MJ; Zhang L; Stippler E; Drazer G; Lin Y; Raines K; Yu L; Coutant CA; Grady H; Krämer J; Pope-Miksinski S; Suarez-Sharp S AAPS J; 2019 Jan; 21(2):21. PubMed ID: 30690680 [TBL] [Abstract][Full Text] [Related]
2. Dissolution and Translational Modeling Strategies Enabling Patient-Centric Drug Product Development: the M-CERSI Workshop Summary Report. Abend A; Heimbach T; Cohen M; Kesisoglou F; Pepin X; Suarez-Sharp S AAPS J; 2018 Apr; 20(3):60. PubMed ID: 29633092 [TBL] [Abstract][Full Text] [Related]
3. Dissolution and Translational Modeling Strategies Toward Establishing an In Vitro-In Vivo Link-a Workshop Summary Report. Heimbach T; Suarez-Sharp S; Kakhi M; Holmstock N; Olivares-Morales A; Pepin X; Sjögren E; Tsakalozou E; Seo P; Li M; Zhang X; Lin HP; Montague T; Mitra A; Morris D; Patel N; Kesisoglou F AAPS J; 2019 Feb; 21(2):29. PubMed ID: 30746576 [TBL] [Abstract][Full Text] [Related]
4. Applications of Clinically Relevant Dissolution Testing: Workshop Summary Report. Suarez-Sharp S; Cohen M; Kesisoglou F; Abend A; Marroum P; Delvadia P; Kotzagiorgis E; Li M; Nordmark A; Bandi N; Sjögren E; Babiskin A; Heimbach T; Kijima S; Mandula H; Raines K; Seo P; Zhang X AAPS J; 2018 Aug; 20(6):93. PubMed ID: 30151612 [TBL] [Abstract][Full Text] [Related]
5. In Vitro Dissolution Profiles Similarity Assessment in Support of Drug Product Quality: What, How, When-Workshop Summary Report. Suarez-Sharp S; Abend A; Hoffelder T; Leblond D; Delvadia P; Kovacs E; Diaz DA AAPS J; 2020 May; 22(4):74. PubMed ID: 32430592 [TBL] [Abstract][Full Text] [Related]
6. In Vitro Biopredictive Methods: A Workshop Summary Report. Pepin XJH; Dressman J; Parrott N; Delvadia P; Mitra A; Zhang X; Babiskin A; Kolhatkar V; Seo P; Taylor LS; Sjögren E; Butler JM; Kostewicz E; Tannergren C; Koziolek M; Kesisoglou F; Dallmann A; Zhao Y; Suarez-Sharp S J Pharm Sci; 2021 Feb; 110(2):567-583. PubMed ID: 32956678 [TBL] [Abstract][Full Text] [Related]
7. Applications of Physiologically Based Biopharmaceutics Modeling (PBBM) to Support Drug Product Quality: A Workshop Summary Report. Mitra A; Suarez-Sharp S; Pepin XJH; Flanagan T; Zhao Y; Kotzagiorgis E; Parrott N; Sharan S; Tistaert C; Heimbach T; Zolnik B; Sjögren E; Wu F; Anand O; Kakar S; Li M; Veerasingham S; Kijima S; Lima Santos GM; Ning B; Raines K; Rullo G; Mandula H; Delvadia P; Dressman J; Dickinson PA; Babiskin A J Pharm Sci; 2021 Feb; 110(2):594-609. PubMed ID: 33152375 [TBL] [Abstract][Full Text] [Related]
8. Best Practices in the Development and Validation of Physiologically Based Biopharmaceutics Modeling. A Workshop Summary Report. Parrott N; Suarez-Sharp S; Kesisoglou F; Pathak SM; Good D; Wagner C; Dallmann A; Mullin J; Patel N; Riedmaier AE; Mitra A; Raines K; Butler J; Kakhi M; Li M; Zhao Y; Tsakalozou E; Flanagan T; Dressman J; Pepin X J Pharm Sci; 2021 Feb; 110(2):584-593. PubMed ID: 33058891 [TBL] [Abstract][Full Text] [Related]
9. Current State and Future Expectations of Translational Modeling Strategies to Support Drug Product Development, Manufacturing Changes and Controls: A Workshop Summary Report. Pepin XJH; Parrott N; Dressman J; Delvadia P; Mitra A; Zhang X; Babiskin A; Kolhatkar V; Suarez-Sharp S J Pharm Sci; 2021 Feb; 110(2):555-566. PubMed ID: 32380182 [TBL] [Abstract][Full Text] [Related]
10. First-Principles and Empirical Approaches to Predicting In Vitro Dissolution for Pharmaceutical Formulation and Process Development and for Product Release Testing. Zaborenko N; Shi Z; Corredor CC; Smith-Goettler BM; Zhang L; Hermans A; Neu CM; Alam MA; Cohen MJ; Lu X; Xiong L; Zacour BM AAPS J; 2019 Feb; 21(3):32. PubMed ID: 30790200 [TBL] [Abstract][Full Text] [Related]
11. Developing Clinically Relevant Dissolution Specifications for Oral Drug Products-Industrial and Regulatory Perspectives. McAllister M; Flanagan T; Boon K; Pepin X; Tistaert C; Jamei M; Abend A; Kotzagiorgis E; Mackie C Pharmaceutics; 2019 Dec; 12(1):. PubMed ID: 31878006 [TBL] [Abstract][Full Text] [Related]
19. Regulatory Experience with Continuous Manufacturing and Real Time Release Testing for Dissolution in New Drug Applications. Kakhi M; Li J; Dorantes A J Pharm Sci; 2023 Oct; 112(10):2604-2614. PubMed ID: 37572781 [TBL] [Abstract][Full Text] [Related]
20. Regulatory perspectives on in vitro (dissolution)/in vivo (bioavailability) correlations. Uppoor VR J Control Release; 2001 May; 72(1-3):127-32. PubMed ID: 11389991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]